Publications
26
Citations
4,043
Est. group size
~5
Recurring co-author estimate
Active years
7
Publishing since 2020
This researcher's work spans infectious disease and drug discovery, including studies on SARS-CoV-2 transmission and evolution, Clostridioides difficile infection and its bacteriophages, and the development of small-molecule and nanoparticle-based therapeutics such as niclosamide analogs and lipid nanoparticles for RNA delivery. The research combines genomic epidemiology, microbiology, and medicinal chemistry approaches to study infections and design potential treatments. Prospective students would likely engage with topics ranging from pathogen genomics to drug and gene-delivery development.
Publication output rose sharply from 2020 to a peak in 2021-2022, then declined through 2023-2026, suggesting a burst of COVID-19-related activity followed by a slowdown.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Discovery of Niclosamide Analogs with Potent Mitochondrial Uncoupling Activity and Reduced Mitochondrial Inhibition–Associated Toxicity
ACS Medicinal Chemistry Letters · 2026
- Discovery of Niclosamide Analogs with Potent Mitochondrial Uncoupling Activity with reduced toxicity
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Cholesterol‐Amino‐Phosphate (CAP) Derived Lipid Nanoparticles for Delivery of Self‐Amplifying RNA and Restoration of Spermatogenesis in Infertile Mice
Advanced Science · 2023
- Clostridioides difficile infection: traversing host–pathogen interactions in the gut
Microbiology · 2023
- Regulatory Role of Anti-Sigma Factor RsbW in Clostridioides difficile Stress Response, Persistence, and Infection
Journal of Bacteriology · 2023
- Nanomaterials for Therapeutic Nucleic Acid Delivery
2023
- Novel <i>Escherichia coli</i> -Infecting Bacteriophages Isolated from Uganda That Target Human Clinical Isolates
PHAGE · 2023
- Abstract 3106: Design, synthesis, and screening of niclosamide analogs as androgen receptor degraders for hepatocellular carcinoma
Cancer Research · 2023
- Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission
Nature Communications · 2022
- Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission
Nature Communications · 2022
- Diversity, Dynamics and Therapeutic Application of Clostridioides difficile Bacteriophages
Viruses · 2022
- Author Correction: SARS-CoV-2 evolution during treatment of chronic infection
Nature · 2022
- Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature · 2022
- The regulatory role of anti-sigma factor, RsbW, in <i>Clostridioides difficile</i> stress response, persistence and infection
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- Nanomaterials for Therapeutic Nucleic Acid Delivery
2022
- Nature×4
- Nature Communications×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Cell×1
- Cell Reports×1
- Nathan Feirer
Medicine · Indiana University
- Cong Zeng
Medicine · The Ohio State University
- Mahesh KC
Medicine · The Ohio State University
- Jaffar A. Al‐Tawfiq
Medicine · Indiana University
- Hadi M. Yassine
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile